Multifocal motor neuropathy: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 27: | Line 27: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Revision as of 13:00, 18 March 2025
Multifocal Motor Neuropathy (MMN) is a rare neuromuscular disease characterized by progressive, asymmetric muscle weakness and atrophy. The disease is believed to be caused by autoimmune responses leading to damage of peripheral nerves.
Symptoms
The primary symptoms of MMN are weakness and muscle atrophy, often accompanied by fasciculations and mild sensory changes. The disease typically begins in the hands and gradually progresses to other parts of the body.
Causes
The exact cause of MMN is unknown, but it is believed to be an autoimmune disease. In this case, the body's immune system mistakenly attacks the peripheral nerves, leading to their damage and the subsequent symptoms.
Diagnosis
Diagnosis of MMN is based on clinical symptoms, electromyography (EMG) findings, and the presence of anti-GM1 antibodies in the blood. However, not all patients with MMN have these antibodies, making diagnosis challenging.
Treatment
Treatment for MMN typically involves immunoglobulin therapy, which can help to reduce symptoms and slow the progression of the disease. Other treatments, such as corticosteroids and plasma exchange, may also be used, but their effectiveness is less well established.
Prognosis
The prognosis for individuals with MMN varies. Some people may experience only mild symptoms and have a normal lifespan, while others may experience significant disability. However, MMN does not typically affect life expectancy.
